xenon has been researched along with Apoplexy in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 18 (72.00) | 29.6817 |
2010's | 6 (24.00) | 24.3611 |
2020's | 1 (4.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, F; Dickinson, R; Liang, M | 1 |
Aronowski, J; Britton, GL; Cattano, D; Grotta, J; Huang, SL; Kim, H; McPherson, DD; Peng, T | 1 |
Guo, ZN; Wang, J; Wu, J; Yang, G; Yang, Y; Zhou, HW | 1 |
Adams, R; De Vivo, D; Hurlet-Jensen, A; Pavlakis, SG; Prohovnik, I | 1 |
Albers, GW; Bammer, R; Lansberg, MG; Mlynash, M; Moseley, ME; Olivot, JM; Schwartz, N; Straka, M; Zaharchuk, G | 1 |
Cattano, D; Giunta, F; Gu, J; Limatola, V; Ma, D; Maze, M; Ward, P | 1 |
Abraini, JH; Colloc'h, N; David, HN; Haelewyn, B; Risso, JJ | 1 |
Abraini, JH; Colloc'h, N; Colomb, DG; David, HN; Haelewyn, B; Risso, JJ | 1 |
Franks, NP; James, ML; Jung, JY; Lascola, CD; Lei, B; Maze, M; Pearlstein, RD; Sheng, H; Sheng, SP; Venkatraman, TN; Warner, DS | 1 |
von Kummer, R | 1 |
Abraini, JH; Buisson, A; Chazalviel, L; David, HN; Lemaire, M; Leveille, F; MacKenzie, ET | 1 |
Machida, K; Nakano, H; Ootsu, M | 1 |
Abraini, JH; Buisson, A; David, HN; Lemaire, M; MacKenzie, ET; Nicole, O | 1 |
Warner, DS; Yokoo, N | 1 |
Gupta, R; Jovin, TG; Yonas, H | 1 |
Kaneko, M; Matsuda, M; Ohashi, M; Tsuji, A | 1 |
Bath, PM; Clarke, W; Ghadami, A; Wardlaw, J; Whysall, B; Willmot, M | 1 |
Pindzola, RR; Yonas, H | 1 |
Meyer, JS; Rauch, GM | 1 |
Nakayama, Y; Nomoto, Y; Takano, K; Tanaka, A; Ueno, Y | 1 |
Kashiwagi, S; Kato, S; Kitahara, T; Moroi, J; Nakayama, H; Shirao, S; Wakuta, Y | 1 |
Firlik, AD; Yonas, H | 1 |
Armonda, RA; Rosenwasser, RH | 1 |
Altschuler, EL | 1 |
Fukui, MB; Gebel, JM; Goldstein, S; Jungreis, CA; Kassam, AB; Kilpatrick, MM; Wechsler, LR; Yonas, H | 1 |
4 review(s) available for xenon and Apoplexy
Article | Year |
---|---|
Neuroprotection by the noble gases argon and xenon as treatments for acquired brain injury: a preclinical systematic review and meta-analysis.
Topics: Animals; Argon; Brain Injuries; Brain Ischemia; Heart Arrest; Mice; Neuroprotection; Neuroprotective Agents; Noble Gases; Rats; Stroke; Swine; Xenon | 2022 |
Xenon CT cerebral blood flow in acute stroke.
Topics: Blood Flow Velocity; Brain; Cerebrovascular Circulation; Contrast Media; Humans; Stroke; Tomography, X-Ray Computed; Xenon | 2005 |
Clinical application of cerebrovascular reserve assessment as a strategy for stroke prevention.
Topics: Acidosis; Carotid Artery Diseases; Cerebrovascular Circulation; Humans; Intracranial Arteriosclerosis; Risk Factors; Stroke; Tomography, X-Ray Computed; Xenon | 2000 |
Diagnostic imaging for stroke.
Topics: Cerebral Angiography; Cerebrovascular Circulation; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Stroke; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Xenon | 2000 |
2 trial(s) available for xenon and Apoplexy
Article | Year |
---|---|
Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cerebrovascular Circulation; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide Donors; Nitroglycerin; Stroke; Tomography, X-Ray Computed; Xenon | 2006 |
CT-based assessment of acute stroke: CT, CT angiography, and xenon-enhanced CT cerebral blood flow.
Topics: Acute Disease; Adolescent; Adult; Aged; Brain Infarction; Cerebral Angiography; Cerebrovascular Circulation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Stroke; Thrombolytic Therapy; Tomography, X-Ray Computed; Xenon | 2001 |
19 other study(ies) available for xenon and Apoplexy
Article | Year |
---|---|
Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke.
Topics: Animals; Cell Death; Dose-Response Relationship, Drug; Drug Delivery Systems; Liposomes; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Stroke; Time Factors; Xenon | 2013 |
Xenon-enhanced CT assessment of cerebral blood flow in stroke-in-progress patients with unilateral internal carotid artery or middle cerebral artery stenosis.
Topics: Adult; Aged; Carotid Stenosis; Cerebral Cortex; Female; Humans; Infarction, Middle Cerebral Artery; Male; Middle Aged; Regional Blood Flow; Stroke; Tomography, X-Ray Computed; Xenon | 2013 |
Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Blood Flow Velocity; Cerebrovascular Circulation; Child; Hemodynamics; Humans; Stroke; Vasodilation; Xenon; Young Adult | 2009 |
Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients.
Topics: Adult; Aged; Blood Flow Velocity; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Stroke; Time Factors; Tomography, X-Ray Computed; Xenon | 2009 |
Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion.
Topics: Animals; Brain; Cohort Studies; Disability Evaluation; Disease Models, Animal; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitrogen; Oxygen; Proto-Oncogene Proteins c-akt; Random Allocation; Sex Characteristics; Stroke; Treatment Outcome; Xenon | 2010 |
Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.
Topics: Animals; Brain Ischemia; Catalytic Domain; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Fibrinolysin; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Male; Models, Molecular; Neuroprotective Agents; Protein Conformation; Rats; Rats, Sprague-Dawley; Serine Proteases; Stroke; Tissue Plasminogen Activator; Xenon | 2010 |
Interactions between nitrous oxide and tissue plasminogen activator in a rat model of thromboembolic stroke.
Topics: Animals; Binding Sites; Brain; Disease Models, Animal; Isoflurane; Male; N-Methylaspartate; Neuroprotective Agents; Nitrous Oxide; Rats; Rats, Sprague-Dawley; Stroke; Thromboembolism; Tissue Plasminogen Activator; Xenon | 2011 |
Xenon neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Hypothermia, Induced; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Pilot Projects; Random Allocation; Rats; Rats, Wistar; Stroke; Xenon | 2012 |
Multimodal CT imaging in acute stroke.
Topics: Acute Disease; Cerebral Angiography; Cerebrovascular Circulation; Data Interpretation, Statistical; Humans; Patient Selection; Predictive Value of Tests; Retrospective Studies; Stroke; Tomography, X-Ray Computed; Xenon | 2002 |
Reduction of ischemic brain damage by nitrous oxide and xenon.
Topics: Anesthetics, Inhalation; Animals; Brain Ischemia; Calcium; Cells, Cultured; Excitatory Amino Acid Agonists; Male; Motor Activity; N-Methylaspartate; Neurons; Neuroprotective Agents; Nitrous Oxide; Postural Balance; Rats; Rats, Sprague-Dawley; Stroke; Xenon | 2003 |
[Investigation of cerebral blood volume measurement].
Topics: Adult; Aged; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Stroke; Tomography, X-Ray Computed; Xenon | 2003 |
Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration.
Topics: Anesthetics, Inhalation; Animals; Infarction, Middle Cerebral Artery; Mice; Neuroprotective Agents; Nitrous Oxide; Pulmonary Alveoli; Receptors, N-Methyl-D-Aspartate; Stroke; Xenon | 2004 |
Postischemic nitrous oxide alone versus intraischemic nitrous oxide in the presence of isoflurane: what it may change for neuroprotection against cerebral stroke in the rat.
Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Brain Ischemia; Drug Interactions; Isoflurane; Neuroprotective Agents; Nitrous Oxide; Rats; Stroke; Xenon | 2005 |
Threshold of regional cerebral blood flow for infarction in patients with acute cerebral ischemia.
Topics: Aged; Brain Ischemia; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Stroke; Tomography, X-Ray Computed; Xenon | 2005 |
Why emergency XeCT-CBF should become routine in acute ischemic stroke before thrombolytic therapy.
Topics: Brain Infarction; Brain Ischemia; Cerebrovascular Circulation; Emergency Medical Services; Humans; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Xenon | 2000 |
Diagnostic value of perfusion MRI in classifying stroke.
Topics: Adult; Aged; Aged, 80 and over; Brain Infarction; Cerebrovascular Circulation; Female; Humans; Intracranial Arteriosclerosis; Magnetic Resonance Angiography; Male; Middle Aged; Stroke; Tomography, X-Ray Computed; Xenon | 2000 |
The value of acetazolamide challenge test in the evaluation of acute stroke.
Topics: Acetazolamide; Cerebrovascular Circulation; Humans; Intracranial Embolism; Prognosis; Stroke; Thrombolytic Therapy; Tomography, X-Ray Computed; Xenon | 2000 |
The utility of XeCT cerebral blood flow in the management of acute stroke.
Topics: Brain Ischemia; Cerebrovascular Circulation; Humans; Stroke; Thrombolytic Therapy; Tomography, X-Ray Computed; Xenon | 2000 |
Xenon as neuroprotectant in acute stroke?
Topics: Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Stroke; Xenon | 2001 |